Effect of Doxazosin Monotherapy on Blood Pressure and Plasma Lipids in Patients with Essential Hypertension

Luigi X. Cubeddu(Nova Southeastern University), Alan K. Halperin(United States Department of Veterans Affairs), Paul E. Klotman(Baylor College of Medicine), Ralph Bloomfield(AstraZeneca (United Kingdom)), James L. Pool(Baylor College of Medicine), Bryant I. Pickering(Texas Diabetes & Endocrinology), Edward Nelson(Federal Reserve), Duane G. Wombolt(Norfolk Academy)
American Journal of Hypertension
April 1, 1988
Cited by 30


Related Papers